Impact of empagliflozin on right ventricular parameters and function among patients with type 2 diabetes

Table 3 Spearman’s correlation coefficients for the relationships between changes in right and left ventricular indices over 6 months

	Both groups (n = 90)		Empagliflozin 10 mg (n = 44)		Placebo (n = 46)
	Spearman’s correlation	p-value	Spearman’s correlation	p-value	Spearman’s correlation	p-value
Mass index, g/m²	0.16	0.14	0.30	0.05	0.07	0.64
End diastolic volume index, mL/m²	0.58	< 0.001	0.52	< 0.001	0.54	< 0.001
End systolic volume index, mL/m²	0.43	< 0.001	0.36	0.02	0.44	0.002
Ejection fraction, %	0.30	0.01	0.13	0.40	0.43	0.003

ISSN: 1475-2840